Changes in albumin from pre- to post- surgery in patients with Crohn’s disease was useful [20], changes during the course of the first six months of peritoneal dialysis was significant as well [21], but in the above study from the Netherlands examining albumin changes over the course of three years, there was no effect on cardiovascular disease or mortality [18]. This evidence concerns the gene ALB and cardiovascular disorder.